Setting Standards for Proactive Pharmacovigilance in India
Add bookmark
Setting Standards for Proactive Pharmacovigilance in India
Add bookmark
With more clinical research being conducted India, there is growing pressure to address pharmacovigilance concerns. Dr. Seema Rajsingh, Head- Pharmacovigilance at Biocon, joins Andrea Charles from Pharma IQ, to discuss the main challenges the industry currently faces, setting the standards for proactive pharmacovigilance in India and the strategies Indian pharmaceutical companies are employing to optimise their drug safety teams and pharmacovigilance activities.
[inlinead]
Tags:
Seema Rajsingh
Biocon
pharmacovigilance
clinical research
patient safety
Pharmacovigilance India
India
